CDK6 and Miyoshi myopathy: CDK6 upregulation mediates MM resistance to immunomodulatory drugs (IMiDs) such as Len and Pom.34 PM effectively inhibited CDK6 expression, suggesting that PM combined with IMiDs may benefit MM patients (Fig. 2b).